DTX3L and rheumatoid arthritis: Interestingly, Hong et al. [56] reported that inhibiting the DTX3L gene restrained the cell invasion and secretion of inflammatory factors, suggesting its potential as a therapeutic target for rheumatoid arthritis, a complex autoimmune disease characterized by chronic synovitis of the joints in humans.